GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Price-to-Owner-Earnings

Magle Chemoswed Holding AB (OSTO:MAGLE) Price-to-Owner-Earnings : (As of Jun. 04, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Price-to-Owner-Earnings?

As of today (2024-06-04), Magle Chemoswed Holding AB's share price is kr33.80. Magle Chemoswed Holding AB does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Magle Chemoswed Holding AB's Price-to-Owner-Earnings or its related term are showing as below:


OSTO:MAGLE's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.035
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-04), Magle Chemoswed Holding AB's share price is kr33.80. Magle Chemoswed Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.13. Therefore, Magle Chemoswed Holding AB's PE Ratio for today is 29.91.

As of today (2024-06-04), Magle Chemoswed Holding AB's share price is kr33.80. Magle Chemoswed Holding AB's EPS without NRI for the trailing twelve months (TTM) ended in was kr1.13. Therefore, Magle Chemoswed Holding AB's PE Ratio without NRI for today is 29.91.

During the past 6 years, Magle Chemoswed Holding AB's highest PE Ratio without NRI was 760.78. The lowest was 19.61. And the median was 36.22.


Magle Chemoswed Holding AB Price-to-Owner-Earnings Historical Data

The historical data trend for Magle Chemoswed Holding AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB Price-to-Owner-Earnings Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Magle Chemoswed Holding AB's Price-to-Owner-Earnings

For the Biotechnology subindustry, Magle Chemoswed Holding AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's Price-to-Owner-Earnings falls into.



Magle Chemoswed Holding AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Magle Chemoswed Holding AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=33.80/-3.96
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB  (OSTO:MAGLE) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Magle Chemoswed Holding AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines